NVAC 2-5-03. The Global Certification Commission declares the world polio-free when: No wild poliovirus has been found for at least 3 consecutive years.

Slides:



Advertisements
Similar presentations
1 NACC Membership and Certification NACC Certification Commission © Copyright by National Association of Catholic Chaplains ALL RIGHTS RESERVED 2006.
Advertisements

Module 1 Introduction to the polio endgame rationale and IPV vaccine
Poliomyelitis Surveillance in Ireland 4 th April, 2014.
1 |1 | Countries using and planning to introduce IPV.
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
بسم الله الرحمن الرحيم. IRAN Vaccination policy for post eradication phase Presented by : A. R.ESTEGHAMATI, MD IRAN EPI Manager.
Role of the laboratory in disease surveillance
INPATIENT PROPOSAL INPATIENT PROPOSAL 4 MONTH CERTIFICATION SCHEDULE.
1 |1 | Countries using and planning to introduce IPV.
Global Action Plan for Laboratory Containment of Wild Polioviruses
ERIKA BARRETT TECHNICIAN, BIOLOGICAL SAFETY OFFICE OF RADIATION, CHEMICAL & BIOLOGICAL SAFETY FRIDAY, OCTOBER 3.
August 12, Meaningful Use *** UDOH Informatics Brown Bag Robert T Rolfs, MD, MPH.
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE LIFE SCIENCES Anthony Atkin (Research Impact.
WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.
Completing The Endgame Global Polio Eradication
World Health Organization
UNSD-DFID Project on Improving National Development Indicators: Director’s Meeting 15 – 17 October 2014, New York, NY Matthias Reister, Senior Statistician,
The Evolving 'Polio Endgame' Strategy
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
Update on activities under laboratory containment of wild Polio viruses in India Dr. Rashmi Arora Scientist G & Head Division of Epidemiology & Communicable.
An update from the National Committee on Levee Safety Presented to the TWCA by Karin M. Jacoby, PE, Esq. June 17, of 14An Involved Public and Reliable.
Inter-Departmental Working Group
1 Influenza Vaccination of Health-care Personnel: An Initiative to Improve a Serious Public Health Problem Anand Parekh, MD, MPH Office of Public Health.
National Certification Committee for Polio Eradication Proposed Work Plan Till th IEAG Meeting, New Delhi, March, 2012.
NVAC W. R. Dowdle. Laboratory Containment of Wild Poliovirus in the United States Phase I National Survey and Inventory Final Report January.
Actions Affecting ERCOT Resulting From The Northeast Blackout ERCOT Board Of Directors Meeting April 20, 2004 Sam Jones, COO.
Fiscal Monitoring and Oversight Tecumseh Local School District January 8, 2013 Roger Hardin, Assistant Director Finance Program Services (614)
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
1 Polio Eradication Program in India: Actions in Post-Eradication Phase By Prasanta K. SahaPrasanta K. Saha, M.Sc., FRSS(UK), CSTAT(UK) Sr. Consultant:
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.
Male’ Declaration Work Plan in 2007/08 by Secretariat UNEP.
“Development of the Co-operation within the Convention on Long Range Transboundary Air Pollution” Karin Kindbom IVL Swedish Environmental Research.
4. Solvency II update Catherine Beech 9 October
The TNI National Environmental Laboratory Accreditation Board Update Daniel Hickman, NELAP Board Chair.
Anglophone West School District Education Council Sustainability Study – Bath Elementary and Middle Schools Executive Summary April 23, 2015.
PolioPlus: Keep our Promise to Eradicate Polio PolioPlus: Keep our Promise to Eradicate Polio.
TITLE PolioPlus Update ICC Meeting Amy Edwards 2 October.
1 DISCONTOOLS Activities Update Morgane Delavergne – DISCONTOOLS Project Manager 2 nd December 2008 ETPGAH Mirror Groups meeting – Hotel Châtelain, Brussels.
Friday, October 26, All aboard for a polio-free world! Express train to raise awareness for polio eradication.
Changes in the context of evaluation and assessment: the impact of the European Lifelong Learning strategy Romuald Normand, Institute of Education Lyon,
Millbrook Dam Environmental Assessment Study Dan Marinigh CAO/Secretary-Treasurer Otonabee Region Conservation Authority October 20, 2015 Otonabee Conservation.
Global Polio Eradication Initiative The 'Intensified Effort' 18 May 2008.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Male’ Declaration Male’ Declaration Review of Progress in Phase III by Secretariat UNEP.
The TNI National Environmental Laboratory Accreditation Board Update Daniel Hickman, NELAP Board Chair.
APA CONTRACTS TO POST-2017 ALLOTTEES July 24 - Letter to all Allottees Inviting Comment August 10 - Allottee Response August 21 - Workshop August 28 –
National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
14 March 2002Update on SDoC - USA1 Update on Supplier’s Declaration of Conformity – USA William Hurst Federal Communications Commission Office of Engineering.
Risk of rabies introduction by non- commercial movement of pets Case study: ROMANIA.
February 2015 An introduction to the switch from trivalent to bivalent oral polio vaccines 1.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
IPV ACCEPTABILITY PANCONF 2015 Background/ Why the study? Dr Beckie Tagbo Chief Consultant: Paediatrics and Child Health Institute of Child Health (ICH),
University of Cincinnati Program Review (E-Review)
Poliovirus containment: Explaining the process Laboratory session LS5: Polio containment and Global Health Security Salon Voltaire Accelerating Progress.
Kingdom of Bahrain Dr. Naeema Isa Al Sabaeei 2014
Perspective and Update
Status DETA Ways forward
The next phase of polio eradication and the vaccines used
المرحلة القادمة من القضاء على شلل الأطفال واللقاحات المستخدمة
Georgia Update Jeff Cown Land Protection Branch
Status DETA Ways forward
The next phase of polio eradication and the vaccines used
Nicholas Martyn DG Regional Policy
Preparing for the Switch
What is FASEB? A federation of 30 societies
Database SIG APNIC19 24 February 2005, Kyoto, Japan
The next phase of polio eradication and the vaccines used
Presentation transcript:

NVAC

The Global Certification Commission declares the world polio-free when: No wild poliovirus has been found for at least 3 consecutive years All laboratories have adopted appropriate measures of containment

Appropriate measures of containment assume that: Global polio immunization recommendations remain in force. Immunization rates will likely decrease in the absence of disease.

WHO Global Action Plan for Laboratory Containment GOAL: To minimise the risk of reintroduction of wild polioviruses from the laboratory to the community 2nd edition 2002

Global Action Plan links biosafety measures to polio eradication progress

Laboratory inventory When Regions become polio-free. Encourage Institutions/labs to dispose of unneeded wild poliovirus infectious and potential infectious materials. Establish National Inventories of laboratories retaining such materials.

Update on US National Inventory October 2002: Letters from ASH and inventory packages were mailed to >31,000 institutions with biomedical laboratories. December 31, 2002: Target date for replies

National Laboratory Inventory response rate/category in database 95% of 104 state/local government 93% of 14 federal government 78% of 684 industry/biotech 77% of 865 academic institutions 66% of 5,171 hospitals 57% of 20,717 private laboratories 53% of 4,800 other categories = 59% of 32,355(01/31/03)

National Laboratory Inventory No. institutions with WPV among those reporting 44 of 665 academic institutions 19 of 3,419 hospitals 18 of 535 industry/biotech 13 of 2,561other categories 13 of 11,835 private laboratories 13 of 99 state/local government 05 of 13 federal government = 131 with WPV materials (01/31/03)

National Laboratory Inventory No. labs with WPV of no. surveyed 82 of 53,626 academic institutions 30 of 1,831 federal government 25 of 7,837 industry/biotech 17 of 8,289 hospitals 15 of 254 state/local government 14 of 7,314 private laboratories 12 of 3,609 other categories = 195 of 82,760 (01/31/03)

Next Steps Reminder letters to all non-responders (February and again March) Validate and reconcile database information Telephone follow up (April and May)

Global Certification w hen one year has passed with no evidence of wild poliovirus transmission worldwide. Labs on inventory have one further year to: -dispose of wild poliovirus materials or -implement biosafety measures

BSL-3/polio Activities involving poliovirus permissive cells or animals BSL-3/polioAll activities, including storage BSL-2/polio (within a class II Biosafety Cabinet) Other activities (including bacteriology, etc laboratories) Potential WPV infectious: Clinical Environmental Laboratory Products WPV Infectious: Clinical Environmental Laboratory Products Biosafety Level Laboratory Activity Type of Material Certification phase biosafety measures

Global Certification w hen two years have passed with no evidence of wild poliovirus transmission worldwide. Nations have one further year to: - ensure national containment is complete and -submit documentation to WHO.

Global Certification of Poliovirus Eradication

Post global certification: At some time after certification, international bodies will consider future immunization policies. Potential increased containment will be one of several factors influencing decisions to: continue IPV and OPV or discontinue OPV, with/without switching to IPV